
Adar Poonawalla-backed Poonawalla Fincorp jump 6% on strong Q3
The NBFC stock has grown three-fold in the last two years, from ₹98 on February 12, 2021, to ₹307 in intraday today, after Adar Poonawalla acquired the company.
The NBFC stock has grown three-fold in the last two years, from ₹98 on February 12, 2021, to ₹307 in intraday today, after Adar Poonawalla acquired the company.
The deal is expected to optimise resource allocation as Poonawalla Fincorp focuses on consumer and MSME financing.
The owner of world's biggest vaccine maker is also known for his interest in social causes.
While the initial rollout will be for supplies to the government vaccination programme, commercial open sales may begin early 2023, says Adar Poonawalla.
Serum Institute chief executive Adar Poonawalla, during a media event today, said the company has 200 million doses of vaccine stock available currently.
India has learned a lot and is in a stronger and better position to face any future wave or future pandemics, says Adar Poonawalla.
This multibagger stock has risen from ₹47 per share on February 1, 2021, to ₹283 level currently, after Adar Poonawalla-led Rising Sun Holdings acquired a 60% stake in the company.
Poonawalla says the biggest learning from the pandemic has been the realisation that one should not make forward looking predictions, as things have been changing fast with Covid-19
In an exclusive conversation with Fortune India, the executive chairperson of Biocon says India should immediately start mixing and matching existing vaccines to accelerate the vaccination drive.
The healthcare sector is dominated by family-run firms, some of which have come into prominence in the past year.